Elevated serum IL-8 levels in ataxia telangiectasia. 2010

Sharon A McGrath-Morrow, and J Michael Collaco, and Thomas O Crawford, and Kathryn A Carson, and Maureen A Lefton-Greif, and Pamela Zeitlin, and Howard M Lederman
Division of Pediatric Pulmonology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA. smorrow@jhmi.edu

Serum interleukin (IL)-8 levels were measured in 50 patients with ataxia telangiectasia (A-T) and 22 without A-T. In a cross-sectional study, the geometric mean of IL-8 level was significantly higher in the patients with A-T (P <.0001). Elevated serum IL-8 levels in patients with A-T suggest that systemic inflammation may contribute to the disease phenotype.

UI MeSH Term Description Entries
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females

Related Publications

Sharon A McGrath-Morrow, and J Michael Collaco, and Thomas O Crawford, and Kathryn A Carson, and Maureen A Lefton-Greif, and Pamela Zeitlin, and Howard M Lederman
January 2015, Journal of immunoassay & immunochemistry,
Sharon A McGrath-Morrow, and J Michael Collaco, and Thomas O Crawford, and Kathryn A Carson, and Maureen A Lefton-Greif, and Pamela Zeitlin, and Howard M Lederman
January 1983, The Turkish journal of pediatrics,
Sharon A McGrath-Morrow, and J Michael Collaco, and Thomas O Crawford, and Kathryn A Carson, and Maureen A Lefton-Greif, and Pamela Zeitlin, and Howard M Lederman
August 1993, Clinical and experimental immunology,
Sharon A McGrath-Morrow, and J Michael Collaco, and Thomas O Crawford, and Kathryn A Carson, and Maureen A Lefton-Greif, and Pamela Zeitlin, and Howard M Lederman
November 1972, Lancet (London, England),
Sharon A McGrath-Morrow, and J Michael Collaco, and Thomas O Crawford, and Kathryn A Carson, and Maureen A Lefton-Greif, and Pamela Zeitlin, and Howard M Lederman
March 2020, Pathogens and global health,
Sharon A McGrath-Morrow, and J Michael Collaco, and Thomas O Crawford, and Kathryn A Carson, and Maureen A Lefton-Greif, and Pamela Zeitlin, and Howard M Lederman
January 2014, International journal of immunopathology and pharmacology,
Sharon A McGrath-Morrow, and J Michael Collaco, and Thomas O Crawford, and Kathryn A Carson, and Maureen A Lefton-Greif, and Pamela Zeitlin, and Howard M Lederman
August 1998, The British journal of ophthalmology,
Sharon A McGrath-Morrow, and J Michael Collaco, and Thomas O Crawford, and Kathryn A Carson, and Maureen A Lefton-Greif, and Pamela Zeitlin, and Howard M Lederman
November 1998, European journal of haematology,
Sharon A McGrath-Morrow, and J Michael Collaco, and Thomas O Crawford, and Kathryn A Carson, and Maureen A Lefton-Greif, and Pamela Zeitlin, and Howard M Lederman
June 2002, Antioxidants & redox signaling,
Sharon A McGrath-Morrow, and J Michael Collaco, and Thomas O Crawford, and Kathryn A Carson, and Maureen A Lefton-Greif, and Pamela Zeitlin, and Howard M Lederman
November 1998, Journal of medical virology,
Copied contents to your clipboard!